21.jpeg)
The co-founder of BioNTech said Tuesday it was "highly likely" that its vaccine against the coronavirus works against the mutated strain detected in Britain, but it could also adapt the vaccine if necessary in six weeks. "Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin
The co-founder of BioNTech said Tuesday it was "highly likely" that its vaccine against the coronavirus works against the mutated strain detected in Britain, but it could also adapt the vaccine if necessary in six weeks. "Scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant," said Ugur Sahin
139.jpeg)
260.jpeg)
259.jpeg)
258.jpeg)
